ID: ALA4248563

Max Phase: Preclinical

Molecular Formula: C19H16O6

Molecular Weight: 340.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(/C=C/C=O)c(OC(=O)c2ccccc2OC(C)=O)c1

Standard InChI:  InChI=1S/C19H16O6/c1-13(21)24-17-8-4-3-7-16(17)19(22)25-18-12-15(23-2)10-9-14(18)6-5-11-20/h3-12H,1-2H3/b6-5+

Standard InChI Key:  CRTBQUQTWDTQLN-AATRIKPKSA-N

Associated Targets(Human)

HCT-8 3484 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 340.33Molecular Weight (Monoisotopic): 340.0947AlogP: 3.05#Rotatable Bonds: 6
Polar Surface Area: 78.90Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.09CX LogD: 3.09
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.35Np Likeness Score: 0.15

References

1. Lu S, Obianom ON, Ai Y..  (2018)  Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer.,  28  (17): [PMID:30037494] [10.1016/j.bmcl.2018.07.032]

Source